Our latest study on Pseudomonas aeruginosa bloodstream infections in Switzerland (2010-2022) reveals increasing incidence and antibiotic resistance. Notably, we observed a high incidence in elderly patients, while resistance rates were elevated in young patients. https://lnkd.in/eftRvycY
ANRESIS, the Swiss Centre for Antibiotic Resistance
Higher Education
Swiss surveillance system and research instrument for antibiotic resistance and consumption.
About us
ANRESIS, the Swiss Centre for Antibiotic Resistance is a nationwide, representative surveillance system and research instrument for antibiotic resistance and consumption. It is hosted by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.
- Website
-
https://www.anresis.ch/
External link for ANRESIS, the Swiss Centre for Antibiotic Resistance
- Industry
- Higher Education
- Company size
- 2-10 employees
- Headquarters
- Bern
- Type
- Educational
Locations
-
Primary
Freiburgstrasse 3
Bern, CH
Updates
-
World #Antibiotic Awareness Week #WAAW: The India-specific version of the ANRESIS-guide provides an overview of the #AMR situation in North and West India, laying the groundwork for greater awareness: https://lnkd.in/eNzMUdEd Bundesamt für Gesundheit BAG sitem-insel
Overview of antibiotic resistance in India with Bern-based tool
uniaktuell.unibe.ch
-
ANRESIS, the Swiss Centre for Antibiotic Resistance reposted this
𝗪𝗲𝗹𝘁𝘄𝗲𝗶𝘁𝗲 𝗦𝗲𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘀𝗶𝗲𝗿𝘂𝗻𝗴𝘀𝘄𝗼𝗰𝗵𝗲 𝘇𝘂 𝗔𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗸𝗮𝗿𝗲𝘀𝗶𝘀𝘁𝗲𝗻𝘇𝗲𝗻: Der neue Swiss Antibiotic Resistance Report 2024 (SARR 2024) zeigt, dass der Einsatz von Antibiotika weiterhin rückläufig ist, insbesondere in der Tiermedizin. Gleichzeitig verdeutlicht er, welche Herausforderungen im Hinblick auf den korrekten Gebrauch von Antibiotika und die Bekämpfung von Resistenzen nach wie vor bestehen. Der SARR 2024 wird am 20. November 2024 in einem Webinar im Rahmen der World AMR Awareness Week vorgestellt (WAAW, 18. bis 24. November 2024). Fachleute der Strategie Antibiotikaresistenzen (StAR) werden dabei die aktuellen Herausforderungen im Umgang mit Antibiotikaresistenzen diskutieren. 📃 SARR 2024: https://lnkd.in/e6ssgepw 💻 Webinar: https://lnkd.in/eFMSvkiG 𝗦𝗲𝗺𝗮𝗶𝗻𝗲 𝗺𝗼𝗻𝗱𝗶𝗮𝗹𝗲 𝗱𝗲 𝘀𝗲𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗮̀ 𝗹’𝗮𝗻𝘁𝗶𝗯𝗶𝗼𝗿𝗲́𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲 : le nouveau Swiss Antibiotic Resistance Report 2024 (SARR 2024) montre que l’utilisation d’antibiotiques continue de baisser, en particulier dans la médecine vétérinaire. Parallèlement, il met en évidence les défis qui subsistent en matière d'utilisation correcte des antibiotiques et de lutte contre les résistances. Le SARR 2024 sera présenté lors d’un webinaire le 20 novembre 2024 dans le cadre de la World AMR Awareness Week (WAAW, 18-24 novembre 2024). Des spécialistes de la stratégie Antibiorésistance (StAR) discuteront des défis actuels liés à la gestion des résistances aux antibiotiques. 📃 SARR 2024 : https://lnkd.in/e883fmDs 💻 Webinaire : https://lnkd.in/eMDW2QZ6 𝗦𝗲𝘁𝘁𝗶𝗺𝗮𝗻𝗮 𝗺𝗼𝗻𝗱𝗶𝗮𝗹𝗲 𝗱𝗶 𝘀𝗲𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘇𝘇𝗮𝘇𝗶𝗼𝗻𝗲 𝘀𝘂𝗹𝗹𝗲 𝗿𝗲𝘀𝗶𝘀𝘁𝗲𝗻𝘇𝗲 𝗮𝗴𝗹𝗶 𝗮𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰𝗶: il nuovo Swiss Antibiotic Resistance Report 2024 (SARR 2024) rivela che l’uso di antibiotici è in continua diminuzione, in particolare nella medicina veterinaria. Al contempo evidenzia le sfide ancora da superare per garantire un uso corretto degli antibiotici e lottare contro le resistenze. Il SARR 2024 sarà presentato il 20 novembre 2024 in occasione di un webinar nell’ambito della World AMR Awareness Week (WAAW, 18–24 novembre 2024). Specialisti della Strategia resistenze agli antibiotici Svizzera (StAR) discuteranno le sfide attuali legate alla gestione delle resistenze. 📃 SARR 2024: https://lnkd.in/ezgJj3ir 💻 Webinar: https://lnkd.in/eVJkiPBx #WAAW #AntimicrobialResistance Federal Food Safety and Veterinary Office FSVO Bundesamt für Landwirtschaft BLW Federal Office for the Environment FOEN
-
In a programme on Swiss radio SRF it was discussed why we should pay attention to global AMR trends and the situation in animals. With insights from ANRESIS. Tune in now! https://lnkd.in/eWGW97RS (German, SRF Wissenschaftsmagazin 28.9.24)
-
Antibiotic use also matters for C. difficile incidence rates. Learn more from the ANRESIS poster at the Joint Annual Meeting of SSI/SSM/SSHH 2024 in Bern. https://lnkd.in/ebQPkVuU
PowerPoint Presentation
anresis.ch
-
📰Read our latest study on how the COVID-19 pandemic affected ESCR E. coli and K. pneumoniae bloodstream infections in Switzerland. https://lnkd.in/efA2PU5X
-
-
𝗕𝗲𝗸𝗮̈𝗺𝗽𝗳𝘂𝗻𝗴 𝘃𝗼𝗻 𝗔𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗸𝗮𝗿𝗲𝘀𝗶𝘀𝘁𝗲𝗻𝘇𝗲𝗻: Der Bundesrat hat den neuen One Health-Aktionsplan 2024–2027 im Rahmen der Strategie Antibiotikaresistenzen Schweiz (StAR) verabschiedet. Da resistente Krankheitserreger keine Grenzen kennen, sieht dieser Aktionsplan einen koordinierten, bereichsübergreifenden Ansatz für Mensch, Tier und Umwelt vor. Das Bundesamt für Gesundheit (BAG), das Bundesamt für Lebensmittelsicherheit und Veterinärwesen (BLV), das Bundesamt für Landwirtschaft (BLW) und das Bundesamt für Umwelt (BAFU) sind für die Umsetzung zuständig und arbeiten eng mit den Kantonen und anderen betroffenen Akteuren zusammen. 🗞️ Medienmitteilung: https://lnkd.in/g6mh2CKy ℹ️ StAR: https://lnkd.in/g6Um3ZRR 𝗟𝘂𝘁𝘁𝗲 𝗰𝗼𝗻𝘁𝗿𝗲 𝗹𝗮 𝗿𝗲́𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲 𝗮𝘂𝘅 𝗮𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗾𝘂𝗲𝘀 : le Conseil fédéral a adopté le nouveau plan d’action One Health 2024-2027, dans le cadre de la Stratégie Antibiorésistance Suisse (StAR). Les pathogènes résistants ne connaissant pas de frontières, ce plan d’action propose une approche coordonnée et multisectorielle entre les domaines humain, vétérinaire et de l’environnement. L'Office fédéral de la santé publique (OFSP), l'Office fédéral de la sécurité alimentaire et des affaires vétérinaires (OSAV), l'Office fédéral de l'agriculture (OFAG) et l'Office fédéral de l'environnement (OFEV) sont responsables de la mise en œuvre et collaborent étroitement avec cantons et autres acteurs concernés. 🗞️ Communiqué de presse : https://lnkd.in/ganF_mNu ℹ️ StAR : https://lnkd.in/gyEmYrAc 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁𝗮𝗿𝗲 𝗹𝗲 𝗿𝗲𝘀𝗶𝘀𝘁𝗲𝗻𝘇𝗲 𝗮𝗴𝗹𝗶 𝗮𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰𝗶: il Consiglio federale ha adottato il nuovo piano d’azione One Health 2024–2027 della Strategia nazionale contro le resistenze agli antibiotici (StAR). Poiché gli agenti patogeni resistenti agli antibiotici non conoscono barriere, il piano d’azione propone un approccio coordinato e multisettoriale che coinvolge gli ambiti della medicina umana e veterinaria e delle scienze ambientali. L’Ufficio federale della sanità pubblica (UFSP), l’Ufficio federale della sicurezza alimentare e di veterinaria (USAV), l’Ufficio federale dell’agricoltura (UFAG) e l’Ufficio federale dell’ambiente (UFAM) sono responsabili dell’attuazione della strategia e collaborano a stretto contatto con i Cantoni e con altri attori interessati. 🗞️ Comunicato stampa : https://lnkd.in/gizgVdcF ℹ️ StAR : https://lnkd.in/gwdevyGn Federal Office of Public Health FOPH Federal Food Safety and Veterinary Office FSVO Bundesamt für Landwirtschaft BLW Federal Office for the Environment FOEN #OneHealth #Antibiotikaresistenz #antibioresistance #resistanceantibiotique #ResistenzaAgliAntibiotici
-
-
ANRESIS contributed to posters during the 2024 congress @SGAIM_SSMIG including one presented by Sereina M. Graber and others on the contribution of the different prescribers to the overall outpatient antimicrobial consumption https://lnkd.in/dMrmSUA9. Congratulations on your work!
PowerPoint-Präsentation
anresis.ch
-
Best oral communication session SGAIM SSMIG SSGIM 2024 congress. https://lnkd.in/eFHQx9ec 👏❗️Jelena Dunaiceva from Unisanté shares insights on whether family physicians prescribe antibiotics in line with Swiss Society of Infectious Diseases (SSI) guidelines: 🩺📋 Preliminary findings from the Sentinella network suggest not entirely. 📉 While some improvements were seen after guideline implementation, prescriptions for certain conditions still don't align. 😷 Sinusitis and pneumonia showed a decrease in inappropriate prescriptions, but challenges remain for other conditions like pharyngitis and otitis media. 🤔 #SGAIMFK2024 #ResearchGIM #AntibioticPrescriptions #GuidelineAdherence #InfectiousDiseases
-
-
ANRESIS was present at this year's ESCMID Global congress with posters on the WHO target of 60% Access group antibiotics reached by Switzerland (https://lnkd.in/emrMnDqa) and on extended-spectrum cephalosporin resistances during the COVID-19 pandemic (https://lnkd.in/eAVQkZ-M).
PowerPoint Presentation
anresis.ch